Tag: (ASX:4DX)
4DMedical partners with Jones Radiology to expand XV technology
4DMedical announced a new commercial contract with Jones Radiology, a provider of diagnostic imaging services across South Australia.
4DMedical boosts US and Australia expansion with $30M ATM facility
4DMedical announced today that it has secured an At-the-Market (ATM) funding facility with Alpha Investment Partners (AIP) to enhance its capital management program.
4DMedical teams up with Vanderbilt University for burn pit research
Respiratory imaging technology innovator 4DMedical Limited announced today its collaboration with Vanderbilt University Medical Center (VUMC) as part of a research grant awarded by the US Department of Veterans Affairs (VA).
4DMedical wraps up Imbio acquisition, strengthens diagnostic precision
Respiratory imaging technology company 4DMedical Limited has successfully completed the acquisition of Imbio, a leading US-based medical technology company specialising in artificial intelligence (AI) applications for personalised medicine.
4DMedical expands with Imbio acquisition and successful equity raise
Respiratory imaging technology company 4DMedical Limited has officially inked a binding agreement for the acquisition of Imbio, a pioneering US-based medical technology company.
Philips, 4DMedical ink MoU to boost respiratory imaging solutions for veterans
Respiratory imaging technology company 4DMedical Limited has entered into a Memorandum of Understanding (MoU) with global healthcare company Koninklijke Philips to broaden federal and commercial sales opportunities for XV Technology in North America.
4DMedical expands lung imaging tech with SaaS deals in Detroit and Memphis
Respiratory imaging technology company 4DMedical Limited has officially inked agreements to provide XV LVAS scans at imaging facilities within the Detroit and Memphis communities.
4DMedical gets US FDA green light clearance for CT-based ventilation product
Respiratory imaging technology company 4DMedical Limited announced the receipt of clearance from the US Food and Drug Administration (FDA) for its CT-based ventilation product CT LVAS.
4DMedical completes $20m placement for respiratory imaging platform commercialisation
Respiratory imaging technology company 4DMedical Limited has completed a share placement worth $20 million to accelerate the commercialisation of its four-dimensional respiratory imaging platform.
4DMedical receives $9.4 million payment following XV Scanner production progress
4DMedical, a respiratory imaging technology provider, has received $9.4 million from the Medical Research Future Fund (MRFF) after successfully reaching a production milestone for the XV Scanner, the world’s first dedicated lung scanner.
Featured Article
Data-rich or data-poor: Where should manufacturers focus their AI efforts?
Over the past year, manufacturers worldwide have made significant strides in adopting artificial intelligence technologies, moving beyond the initial hype to tangible implementations that deliver real business value.
